7515.T
The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
Business. The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
The company's capital structure is characterized by a debt-to-equity ratio of 1.94, indicating a relatively high reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 0.45, suggesting limited short-term liquidity to cover immediate liabilities. The company's price-to-book ratio of 1.29 and price-to-tangible-book ratio of 1.29 indicate that the market values the company slightly above its book value, but not significantly so.
Profitability metrics show a return on equity of 4.01% and a return on assets of 0.79%, both of which are below the industry median for the Food Retail & Distribution sector. The company's operating margin is 0.68%, and its net margin is 0.31%, which are also below the industry median, indicating that the company is underperforming in terms of profitability relative to its peers.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the company's exposure to regional economic fluctuations and regulatory changes. The company's revenue is primarily generated from the sale of food and drug products, with no significant diversification into other product lines or services.
The company's growth trajectory is expected to remain flat, with no significant revenue growth projected for the current fiscal year. The company's revenue has remained relatively stable over the past few years, with no significant increases or decreases. The company's capital expenditure is negative, indicating that it is not investing in new assets or expanding its operations.
The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could impact its ability to meet short-term obligations. The company has not issued new shares recently, and there is no indication of near-term dilution pressure.
Recent events and filings indicate that the company has not issued any new shares or raised additional capital. The company's recent financial performance has been stable, with no significant changes in its revenue or profitability. The company's management has not disclosed any major strategic initiatives or capital expenditures in recent filings.
- The company has a high debt-to-equity ratio, indicating a significant reliance on debt financing.
- The company's profitability metrics are below the industry median, suggesting underperformance in terms of returns.
- The company's revenue is concentrated in a single business segment, increasing its exposure to regional economic fluctuations.
- The company's growth trajectory is expected to remain flat, with no significant revenue growth projected.
- The company has a medium liquidity risk and a low dilution risk, with no indication of near-term dilution pressure.
- "margin_outlook_rationale": "The company's operating margin is expected to remain stable due to consistent cost management and pricing strategies.",
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 7515.T Market data — financials · 2026-05-27
- Maruyoshi Center Inc Market data — analyst estimates · 2026-05-27